中华消化杂志
中華消化雜誌
중화소화잡지
Chinese Journal of Digestion
2009年
4期
245-248
,共4页
吴高珏%林琳%罗云%张红杰%李学良
吳高玨%林琳%囉雲%張紅傑%李學良
오고각%림림%라운%장홍걸%리학량
糖尿病%锌原卟啉%胃肠活动%大鼠
糖尿病%鋅原卟啉%胃腸活動%大鼠
당뇨병%자원계람%위장활동%대서
Diabetes mellitus%Zinc protoporphyrin%Gastrointestinal motility%Rat
目的 探讨血红素氧合酶(HO)阻滞剂锌原卟啉(ZnPP)对糖尿病(DM)大鼠结肠动力和Cajal间质细胞(ICC)的影响.方法 雄性SD大鼠腹腔注射链脲佐菌素(STZ),3 d后选取成功造模大鼠24只作为DM组,另取正常大鼠16只作为对照组.饲养6周时,选取DM组大鼠和对照组大鼠各8只,行碳末推进实验,确认有无胃肠动力障碍.剩余DM组大鼠第6周起予以干预,DM未干预组(8只)0.1 mol/L磷酸盐缓冲液腹腔注射,隔日1次,连续3周;DM+ZnPP组(8只),ZnPP 10 μmol/kg腹腔注射,隔日1次,连续3周.对照组(8只)予以膜腔注射0.1 mmol/L磷酸盐缓冲液.Western印迹法检测结肠组织HO-1、HO-2和c-kit表达.免疫组化法测定结肠组织HO-1、HO-2和c-kit阳性细胞面积.结果 DM未干预组胃肠推进指数为(63.0±1.2)%,较对照组显著减低[(71.85:2.0)%,P<0.05];而DM+ZnPP组胃肠推进指数为(72.5±2.6)%,较DM未干预组明显改善(P<0.05),且与对照组差异无统计学意义(P>0.05).DM+ZnPP组近、远端结肠HO-1表达明显下降(P<0.05).DM未干预组和DM+ZnPP组近端结肠HO-2表达均较对照组显著减少(P<0.05).DM未干预组近、远端结肠组织c-kit较对照组显著减少(P<0.05);DM+ZnPP组c-kit的表达较DM未干预组明显改善(P<0.05),且与对照组间差异无统计学意义(P>0.05).结论 ZnPP可能通过阻滞HO-1对DM大鼠结肠Cajal间质细胞有保护作用,并改善其结肠动力障碍.
目的 探討血紅素氧閤酶(HO)阻滯劑鋅原卟啉(ZnPP)對糖尿病(DM)大鼠結腸動力和Cajal間質細胞(ICC)的影響.方法 雄性SD大鼠腹腔註射鏈脲佐菌素(STZ),3 d後選取成功造模大鼠24隻作為DM組,另取正常大鼠16隻作為對照組.飼養6週時,選取DM組大鼠和對照組大鼠各8隻,行碳末推進實驗,確認有無胃腸動力障礙.剩餘DM組大鼠第6週起予以榦預,DM未榦預組(8隻)0.1 mol/L燐痠鹽緩遲液腹腔註射,隔日1次,連續3週;DM+ZnPP組(8隻),ZnPP 10 μmol/kg腹腔註射,隔日1次,連續3週.對照組(8隻)予以膜腔註射0.1 mmol/L燐痠鹽緩遲液.Western印跡法檢測結腸組織HO-1、HO-2和c-kit錶達.免疫組化法測定結腸組織HO-1、HO-2和c-kit暘性細胞麵積.結果 DM未榦預組胃腸推進指數為(63.0±1.2)%,較對照組顯著減低[(71.85:2.0)%,P<0.05];而DM+ZnPP組胃腸推進指數為(72.5±2.6)%,較DM未榦預組明顯改善(P<0.05),且與對照組差異無統計學意義(P>0.05).DM+ZnPP組近、遠耑結腸HO-1錶達明顯下降(P<0.05).DM未榦預組和DM+ZnPP組近耑結腸HO-2錶達均較對照組顯著減少(P<0.05).DM未榦預組近、遠耑結腸組織c-kit較對照組顯著減少(P<0.05);DM+ZnPP組c-kit的錶達較DM未榦預組明顯改善(P<0.05),且與對照組間差異無統計學意義(P>0.05).結論 ZnPP可能通過阻滯HO-1對DM大鼠結腸Cajal間質細胞有保護作用,併改善其結腸動力障礙.
목적 탐토혈홍소양합매(HO)조체제자원계람(ZnPP)대당뇨병(DM)대서결장동력화Cajal간질세포(ICC)적영향.방법 웅성SD대서복강주사련뇨좌균소(STZ),3 d후선취성공조모대서24지작위DM조,령취정상대서16지작위대조조.사양6주시,선취DM조대서화대조조대서각8지,행탄말추진실험,학인유무위장동력장애.잉여DM조대서제6주기여이간예,DM미간예조(8지)0.1 mol/L린산염완충액복강주사,격일1차,련속3주;DM+ZnPP조(8지),ZnPP 10 μmol/kg복강주사,격일1차,련속3주.대조조(8지)여이막강주사0.1 mmol/L린산염완충액.Western인적법검측결장조직HO-1、HO-2화c-kit표체.면역조화법측정결장조직HO-1、HO-2화c-kit양성세포면적.결과 DM미간예조위장추진지수위(63.0±1.2)%,교대조조현저감저[(71.85:2.0)%,P<0.05];이DM+ZnPP조위장추진지수위(72.5±2.6)%,교DM미간예조명현개선(P<0.05),차여대조조차이무통계학의의(P>0.05).DM+ZnPP조근、원단결장HO-1표체명현하강(P<0.05).DM미간예조화DM+ZnPP조근단결장HO-2표체균교대조조현저감소(P<0.05).DM미간예조근、원단결장조직c-kit교대조조현저감소(P<0.05);DM+ZnPP조c-kit적표체교DM미간예조명현개선(P<0.05),차여대조조간차이무통계학의의(P>0.05).결론 ZnPP가능통과조체HO-1대DM대서결장Cajal간질세포유보호작용,병개선기결장동력장애.
Objective To assess the effects of zinc protoporphyrin (ZnPP), an inhibitor of the heme oxygenase (HO), on the colonic interstitial cells of Cajal (ICC) of diabetic rats with colonic slow transit. Methods Diabetes mellitus (DM) model was induced by intraperitoneal injection of streptozotocin (STZ) in Sprague-Dawley rats. Twenty four successfully established DM rats were selected, and 16 healthy rats were served as controls. Six weeks later, gastrointestional (GI) dysfunction was observed by charcoal propulsion experiment in 8 DM rats and 8 controls. The rest rats in DM group were divided into 2 groups: DM rats intraperitoneal injected with PBS (n=8) or with 10 μmol/kg of ZnPP (n = 8) every other day for 3 weeks. The rats in control group (n = 8) were intraperitoneally injected with PBS. The levels of HO and c-kit (the special receptor of ICC) expression were detected by Western blotting. The distribution of ICC was observed by immunohistochemistry and the area of c-kit positive cells was counted. Results The GI propulsion rate in DM rats interfered with PBS was significantly declined compared to that in the controls (63.0%± 1.2% vs 71.8%±2.0%, P<0.05). But it was improved in DM rats interfered with ZnPP (72.5± 2.6%, P<0.05), which showed no significant differentee with that in control group (P>0.05). The expression of HO-1 in close and distant colon of DM rats interfered with ZnPP was decreased (P< 0.05). The expression of HO-2 in close colon and the area of c-kit positive cells of DM rats interfered with PBS was reduced compared with that in controls (P<0.05), but both were improved in DM rats interfered with ZnPP (P<0. 05). Conclusion Administration of ZnPP might be able to protect ICC by its blockage of HO-1 in DM rats with gastrointestinal dysfunction.